What's new

Human medicines European public assessment report (EPAR): Zolsketil pegylated liposomal, doxorubicin, Date of authorisation: 31/05/2022, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Zolsketil pegylated liposomal, doxorubicin, Date of authorisation: 31/05/2022, Revision: 4, Status: Authorised

Mar 13, 2025 - 15:55
 0
Human medicines European public assessment report (EPAR): Zolsketil pegylated liposomal, doxorubicin, Date of authorisation: 31/05/2022, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Zolsketil pegylated liposomal, doxorubicin, Date of authorisation: 31/05/2022, Revision: 4, Status: Authorised
Read More

Tags:

Previous Article

European Shortages Monitoring Platform (ESMP) training on crisis and MSSG-led pr...

Next Article

EMEA-000205-PIP02-11-M06

Related Posts

Human medicines European public assessment report (EPAR): Pemetrexed Fresenius Kabi, pemetrexed, Date of authorisation: 22/07/2016, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0

Human medicines European public assessment report (EPAR): Lydisilka, estetrol,drospirenone, Date of authorisation: 19/05/2021, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Sutent, sunitinib, Date of authorisation: 19/07/2006, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 10, 2025  0